Our Facilities
hADME Pharmacology Studies
Better Answers, Sooner
Clinical pharmacology unit services backed by experienced staff and proven expertise.
hADME studies are critical to predicting how a drug behaves in the body—and we make sure you’re ahead of the curve. At AXIS, our hADME services help you:
- Design smarter formulations based on how your drug is absorbed, distributed, metabolized, and excreted.
- Enhance safety and dosing precision, reducing the risk of setbacks and boosting confidence in your next stage.
- Streamline clinical trial strategy, by using hADME data to shape efficient, patient-focused study designs.
Our expert team—supported by dedicated clinical trial units, monitoring protocols, and hot labs for sample analysis—acts as an extension of your organization from Day 1.
Faster insights, tighter timelines, and more clarity on your path to development.
Rapid Recruitment Keeps Your Dermatology Clinical Trial on Track
Quick enrollment is critical to maintaining momentum in dermatology clinical trials.
At AXIS, our proactive recruitment strategies are designed to accelerate enrollment and keep it steady—so you can reach milestones faster without disruption.
With a large volunteer database, a strategic location near major universities, and strong community partnerships, we ensure your enrollment goals are met on time and with confidence.
- Expansive Volunteer Database Access a broad, engaged pool of healthy volunteers to meet enrollment targets without delays.
- Strategic Location Our site’s proximity to universities and diverse communities provides a steady stream of eligible participants.
- Community Involvement Long-standing community ties build trust and drive consistent participation across studies..
- Quick Start-up Optimized processes mean your first patients are enrolled within weeks, not months.
AXIS Mexico
Since 2011, AXIS Mexico has supported sponsors with 400+ studies conducted over the past decade, helping major pharmaceutical companies register products in Mexico and across Latin America.
Recognized by COFEPRIS and ISP Chile, we are a trusted partner for bioequivalence and clinical research in the region.
Our 70+ dedicated professionals bring deep expertise in clinical development and regulatory compliance, ensuring accurate results that meet global and regional standards.
- Two Clinical Pharmacology Units with 330+ beds for large-scale bioequivalence studies.
- Four advanced LC-MS/MS systems delivering reliable, high-quality bioanalytical data.
- The distinction of being the only CRO in Mexico approved for studies involving controlled substances.
With this unique positioning, AXIS Mexico provides sponsors with the speed, reliability, and compliance needed to move trials forward confidently in Latin America.